Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1974 Mar 1;139(3):528-42.
doi: 10.1084/jem.139.3.528.

Influence of dose and route of antigen injection on the immunological induction of T cells

Influence of dose and route of antigen injection on the immunological induction of T cells

P H Lagrange et al. J Exp Med. .

Abstract

Delayed-type hypersensitivity (DTH) develops in the absence of an adjuvant when mice are injected intravenously or subcutaneously with an appropriate dose of sheep red blood cells (SRBC). The optimal intravenous dose of 10(5) SRBC (in CD-1 mice) produces maximum DTH which decays exponentially from its peak on day 4. Increasing the dose of SRBC reduces and eventually abolishes all evidence of DTH. DTH fails to reappear in respose to secondary stimulation except in splenectomized mice in whom the development of DTH is not suppressed, even by massive doses of SRBC. Hence the suppression cannot be due to antigen as such. The optimal dose of SRBC for sensitization by footpad inoculation is 100-fold higher (10(7) SRBC in CD-1 mice), but even 10(9) SRBC do not block the induction of DTH by this route of immunization. A blocking dose of SRBC, given intravenously 1 day before footpad inoculation, completely suppresses cell proliferation in the draining lymph node, prevents PFC production there, and blocks the induction of DTH by a sensitizing dose of SRBC. If given 1 day after footpad sensitization, intravenous antigen has little effect on the cellular response in the regional node but DTH is still completely suppressed. Blocking of induction and expression may depend, therefore, on different mechanisms.

PubMed Disclaimer

References

    1. J Exp Med. 1972 Sep 1;136(3):499-513 - PubMed
    1. J Natl Cancer Inst. 1973 Nov;51(5):1655-67 - PubMed
    1. J Natl Cancer Inst. 1973 Nov;51(5):1669-76 - PubMed
    1. J Immunol. 1965 Jul;95:26-38 - PubMed
    1. Nature. 1960 Jul 30;187:434-5 - PubMed